Ask AI
ProCE Banner Activity

Novel Agents, New Combinations: An Expert Overview of Unmet Needs and Emerging Therapies for DLBCL 

Slideset

Download slides to review key data on contemporary paradigms and novel strategies for managing DLBCL.

Released: January 30, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Target Audience

This activity is intended for hematologists, oncologists, and other healthcare professionals caring for patients with DLBCL.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate emerging evidence for novel treatments for DLBCL and their potential application to clinical practice

  • Educate colleagues and patients on the mechanism of action and clinical rationale for novel agents and combination therapies in DLBCL

  • Select optimal treatments for patients with previously untreated DLBCL, considering expert recommendations along with available efficacy and safety evidence

  • Recommend clinical trials evaluating novel treatments for eligible patients with DLBCL